NLRX1 Antikörper (AA 45-205) (Biotin)
-
- Target Alle NLRX1 Antikörper anzeigen
- NLRX1 (NLR Family Member X1 (NLRX1))
-
Bindungsspezifität
- AA 45-205
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NLRX1 Antikörper ist konjugiert mit Biotin
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human NLR family member X1 protein (45-205AA)
- Isotyp
- IgG
- Top Product
- Discover our top product NLRX1 Primärantikörper
-
anti-NLR Family Member X1 (NLRX1) (AA 581-630) antibody
NLRX1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-NLR Family Member X1 (NLRX1) (AA 580-630) antibodyNLRX1 Reaktivität: Human, Ratte, Maus, Pferd, Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-NLR Family Member X1 (NLRX1) (Internal Region) antibodyNLRX1 Reaktivität: Human, Ratte, Maus WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-NLR Family Member X1 (NLRX1) (AA 111-210) antibodyNLRX1 Reaktivität: Human WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-NLR Family Member X1 (NLRX1) (AA 87-360) antibodyNLRX1 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-NLR Family Member X1 (NLRX1) (AA 45-205) antibodyNLRX1 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-NLR Family Member X1 (NLRX1) (Internal Region) antibodyVerified NLRX1 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- NLRX1 (NLR Family Member X1 (NLRX1))
- Andere Bezeichnung
- NLRX1 (NLRX1 Produkte)
- Hintergrund
-
Background: Participates in antiviral signaling. Acts as a negative regulator of MAVS-mediated antiviral responses, through the inhibition of the virus-induced RLH (RIG-like helicase)-MAVS interaction (PubMed:18200010). Has no inhibitory function on NF-Kappa-B and type 1 interferon signaling pathways, but enhances NF-Kappa-B and JUN N-terminal kinase dependent signaling through the production of reactive oxygen species (PubMed:18219313).
Aliases: Caterpiller protein 11.3 antibody, CLR11.3 antibody, DLNB26 antibody, FLJ21478 antibody, MGC131937 antibody, MGC21025 antibody, NLR family member X1 antibody, NLR family, X1 antibody, Nlrx1 antibody, NLRX1_HUMAN antibody, NOD-like receptor X1 antibody, NOD26 antibody, NOD5 antibody, NOD9 antibody, Nucleotide-binding oligomerization domain protein 26 antibody, Nucleotide-binding oligomerization domain protein 5 antibody, Nucleotide-binding oligomerization domain protein 9 antibody, nucleotide-binding oligomerization domain, leucine rich repeat containing X1 antibody, Protein Caterpiller 11.3 antibody
- UniProt
- Q86UT6
- Pathways
- SARS-CoV-2 Protein Interaktom
-
